BEST UNLIMITED TURBO LONG CERTIFICATE - MEDTRONIC Share Price

Certificat

FC98S

DE000SW26AT6

Market Closed - Euronext Paris 17:30:01 15/05/2024 BST
6.295 EUR +0.10% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - MEDTRONIC
Current month+7.70%
1 month+5.65%
Date Price Change
15/05/24 6.241 -0.76%
14/05/24 6.289 +0.64%
13/05/24 6.249 +3.24%
10/05/24 6.053 +0.58%
09/05/24 6.018 +1.55%

Real-time Euronext Paris

Last update May 15, 2024 at 05:30 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
FC98S
ISINDE000SW26AT6
Date issued 07/09/2023
Strike 50.17 $
Maturity Unlimited
Parity 5 : 1
Emission price 6.03
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.404
Lowest since issue 3.948
Spread 0.008
Spread %0.13%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
84.72 USD
Average target price
94.77 USD
Spread / Average Target
+11.87%
Consensus
  1. Stock Market
  2. Certificates
  3. FC98S Certificat